NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

從醫生的角度看,新型冠狀病毒感染(COVID-19)對遠程醫療的影響

Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine, a Physician Perspective

出版商 GlobalData 商品編碼 967329
出版日期 內容資訊 英文 51 Pages
訂單完成後即時交付
價格
從醫生的角度看,新型冠狀病毒感染(COVID-19)對遠程醫療的影響 Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine, a Physician Perspective
出版日期: 2020年10月19日內容資訊: 英文 51 Pages
簡介

隨著患者,醫療系統和出資者越來越意識到技術的潛力,人們普遍預計COVID-19將成為遠程醫療的轉折點。由於大流行,用於報銷和使用遠程醫療的法規和政策已發生了重大變化,導致獲得這些服務的機會增加且需求空前。

本報告調查了新型冠狀病毒感染(COVID-19)對遠程醫療的影響,COVID-19大流行(COVID-19)之前,之中和之後遠程醫療,美國和歐洲的優勢和障礙。法國,德國,意大利,西班牙,英國)□提供信息,例如日本對遠程醫療的分析以及對遠程醫療的未來展望。

目錄

目錄

  • 遠程醫療概述
  • 什麼是遠程醫療?
  • 遠程醫療的類型是什麼?
  • 遠程醫療有什麼好處?
  • 遠程醫療的一般障礙是什麼?
  • COVID-19以及更早的美國,歐洲和日本的遠程醫療行業
  • 美國
  • 歐洲
  • 日本
  • COVID-19之前的遠程醫療部門:調查數據
  • COVID-19之前的遠程醫療行業:區域調查數據
  • 19年來美國,歐洲和日本的COVID-19遠程醫療領域
  • 由於社會距離和封鎖措施,遠程醫療的使用迅速增加
  • 美國遠程醫療法規的大流行變化
  • 由於某些歐洲國家的報銷政策變化,對遠程醫療的需求迅速增加
  • 引入新措施以緩解日本對遠程醫療的限制
  • COVID-19中的遠程醫療部門:調查數據
  • COVID-19中的遠程醫療部門:區域調查數據
  • COVID-19之後的偏遠醫療領域
  • COVID-19之後的遠程醫療的未來
  • COVID-19之後的遠程醫療部門:調查數據
  • 要點

附錄

  • 調查方法
  • 縮寫
  • 參考
  • 相關報告
  • 關於作者
  • 關於GlobalData

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCHT203

Telemedicine is the use of electronic communication for the delivery of remote clinical care. It has been recognized as a critical strategy during the ongoing coronavirus disease 2019 (COVID-19) pandemic to limit the risk of person-to-person transmission of the virus as social distancing has become the norm. It is widely anticipated that COVID-19 may be the tipping point for telemedicine as the full potential of the technology is increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. This case study assesses physician perceptions on telemedicine usage before and during the COVID-19 outbreak in the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan, as well as expected use of telemedicine post-COVID-19. The case study combines information obtained from secondary sources and primary research with specialists and physicians from different therapy areas (oncology, pulmonology, gastroenterology, cardiology, and infectious disease).

Key Highlights

  • The adoption of telemedicine had been increasing before the COVID-19 crisis, but the uptake was still low: Physicians from the European Union (EU) were leading users of telemedicine solutions pre-COVID-19 (72%), which can be attributed to the EU's attempts to enhance the digitization of its healthcare sectors from 2018. In line with the regulatory landscape, Japanese respondents reported the lowest levels of telemedicine usage pre-COVID-19 (42%). Until 2015, the Japanese Ministry of Health, Labour and Welfare (MHLW) had restricted the use of telemedicine solutions except for patients with chronic diseases in remote areas in the country.
  • Use of telemedicine gained momentum during the COVID-19 pandemic when social distancing became the norm: Telemedicine has been recognized as a critical strategy during the COVID-19 emergency to limit the risk of person-to-person transmission, in turn triggering policymakers in many countries to relax regulations to facilitate widespread usage and adoption of telemedicine. Despite easing of restrictions in Japan, over 50% of respondents reported their use of telemedicine had remained unchanged as a result of the COVID-19 pandemic, whereas in the US and EU, over 75% of respondents increased use of the technology.
  • Telemedicine has the potential to significantly improve delivery of healthcare post-COVID-19: Telemedicine has a potential to address ongoing issues faced by healthcare systems worldwide. These include workforce shortages, an aging society, accessing affordable care, and increased healthcare spending. While only 47% of US physicians were using telemedicine pre-COVID-19, 76% were positive that their usage would continue after the crisis ended. This may suggest that at the time of survey fielding, physicians were optimistic about temporary telemedicine flexibilities being made permanent in the US.

Scope

This case study contains the following -

  • An overview of telemedicine, including benefits and barriers
  • A review of the telemedicine sector in the US, Europe, and Japan before the pandemic, including poll data
  • A review of the telemedicine sector in the US, Europe, and Japan during the pandemic, including poll data
  • A review of the telemedicine sector post COVID-19, including poll data

Reasons to Buy

  • Get an overview of the changing telemedicine regulatory landscapes in the US, Europe, and Japan.
  • See how physician use of telemedicine has changed in these regions as a result of the pandemic.
  • See how physician use of telemedicine is expected to change in the future in these regions.

Table of Contents

Table of Contents

  • Telemedicine Overview
  • What Is Telemedicine?
  • What Are the Different Types of Telemedicine?
  • What Are the Benefits of Telemedicine?
  • What Are the Common Barriers to Telemedicine?
  • Telemedicine Sector in the US, Europe, and Japan Before COVID-19
  • In the US, Pre-Pandemic Use of Telemedicine Was Rising But Remained Low Overall
  • In Europe, the UK Was the Most Established 5EU Market for Telemedicine Before COVID-19
  • Use of Telemedicine Is Still at the Infancy Stage in Japan
  • Telemedicine Sector Before COVID-19 - Survey Data
  • Telemedicine Sector Before COVID-19 - Survey Data by Region
  • Telemedicine Sector in the US, Europe, and Japan During COVID-19
  • Social Distancing and Lockdown Measures Have Led to a Surge in Telemedicine Use
  • The Regulatory Landscape for Telemedicine in the US Has Changed Significantly as a Result of the Pandemic
  • Changes to Reimbursement Policies in Some European Countries Have Led to a Surge in Demand for Telemedicine
  • Japan Has Introduced New Measures to Ease Telemedicine Restrictions
  • Telemedicine Sector During COVID-19 - Survey Data
  • Telemedicine Sector During COVID-19 - Survey Data by Region
  • Telemedicine Sector Post-COVID-19
  • The Future of Telemedicine Post-COVID-19
  • Telemedicine Sector Post-COVID-19 - Survey Data
  • Key Takeaways

Appendix

  • Methodology
  • Abbreviations
  • Bibliography
  • Related Reports
  • About the Authors
  • About GlobalData